top of page
Our Services
About
News
Publications
Blog
Contact Us
Contact Us
Careers
More
Use tab to navigate through the menu items.
< Back
La Jolla Labs, Inc. Announces First Patient Treated with Custom Antisense Therapy GBFsen for familial ALS
Biospace
Apr 30, 2026
Press release
Previous
Next
bottom of page
